Literature DB >> 15548683

Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer.

Yu-Wei Leu1, Pearlly S Yan, Meiyun Fan, Victor X Jin, Joseph C Liu, Edward M Curran, Wade V Welshons, Susan H Wei, Ramana V Davuluri, Christoph Plass, Kenneth P Nephew, Tim H-M Huang.   

Abstract

Alterations in histones, chromatin-related proteins, and DNA methylation contribute to transcriptional silencing in cancer, but the sequence of these molecular events is not well understood. Here we demonstrate that on disruption of estrogen receptor (ER) alpha signaling by small interfering RNA, polycomb repressors and histone deacetylases are recruited to initiate stable repression of the progesterone receptor (PR) gene, a known ERalpha target, in breast cancer cells. The event is accompanied by acquired DNA methylation of the PR promoter, leaving a stable mark that can be inherited by cancer cell progeny. Reestablishing ERalpha signaling alone was not sufficient to reactivate the PR gene; reactivation of the PR gene also requires DNA demethylation. Methylation microarray analysis further showed that progressive DNA methylation occurs in multiple ERalpha targets in breast cancer genomes. The results imply, for the first time, the significance of epigenetic regulation on ERalpha target genes, providing new direction for research in this classical signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548683     DOI: 10.1158/0008-5472.CAN-04-2045

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  71 in total

Review 1.  Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.

Authors:  Amy M Dworkin; Tim H-M Huang; Amanda Ewart Toland
Journal:  Semin Cancer Biol       Date:  2009-02-20       Impact factor: 15.707

2.  Heritable clustering and pathway discovery in breast cancer integrating epigenetic and phenotypic data.

Authors:  Zailong Wang; Pearlly Yan; Dustin Potter; Charis Eng; Tim H-M Huang; Shili Lin
Journal:  BMC Bioinformatics       Date:  2007-02-01       Impact factor: 3.169

Review 3.  Quantitative assessment of DNA methylation: Potential applications for disease diagnosis, classification, and prognosis in clinical settings.

Authors:  Romulo Martin Brena; Tim Hui-Ming Huang; Christoph Plass
Journal:  J Mol Med (Berl)       Date:  2006-01-17       Impact factor: 4.599

4.  Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo.

Authors:  Michael Karl; Mariana Berho; Judith Pignac-Kobinger; Gary E Striker; Sharon J Elliot
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

5.  Estrogen receptor-alpha methylation predicts melanoma progression.

Authors:  Takuji Mori; Steve R Martinez; Steven J O'Day; Donald L Morton; Naoyuki Umetani; Minoru Kitago; Atsushi Tanemura; Sandy L Nguyen; Andy N Tran; He-Jing Wang; Dave S B Hoon
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

Review 6.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

7.  Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells.

Authors:  Huey-Jen L Lin; Tao Zuo; Ching-Hung Lin; Chieh Ti Kuo; Sandya Liyanarachchi; Shuying Sun; Rulong Shen; Daniel E Deatherage; Dustin Potter; Lisa Asamoto; Shili Lin; Pearlly S Yan; Ann-Lii Cheng; Michael C Ostrowski; Tim H-M Huang
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

8.  DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells.

Authors:  Jon M McGough; Dafeng Yang; Shuang Huang; David Georgi; Stephen M Hewitt; Christoph Röcken; Marc Tänzer; Matthias P A Ebert; Kebin Liu
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

9.  Epigenetic Therapy in Breast Cancer.

Authors:  Maryam B Lustberg; Bhuvaneswari Ramaswamy
Journal:  Curr Breast Cancer Rep       Date:  2011-03

10.  Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells.

Authors:  Shubin Sheng; Daniel H Barnett; Benita S Katzenellenbogen
Journal:  Mol Cell Endocrinol       Date:  2008-10-04       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.